X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiovascular (60) 60
cardiac & cardiovascular systems (49) 49
humans (43) 43
index medicus (43) 43
abridged index medicus (39) 39
internal medicine (38) 38
heart attacks (35) 35
cardiology and cardiovascular medicine (31) 31
female (31) 31
male (31) 31
middle aged (30) 30
acute coronary syndromes (29) 29
coronary heart disease (23) 23
medical colleges (23) 23
aged (22) 22
care and treatment (22) 22
drug therapy (22) 22
mortality (22) 22
cardiac patients (21) 21
cardiology (20) 20
treatment outcome (20) 20
cardiovascular disease (18) 18
myocardial infarction - drug therapy (17) 17
risk factors (17) 17
heart attack (15) 15
aspirin (14) 14
diabetes (14) 14
double-blind method (13) 13
myocardial-infarction (13) 13
risk assessment (13) 13
acute coronary syndrome (12) 12
confidence intervals (12) 12
ischemia (12) 12
studies (12) 12
analysis (11) 11
blood platelets (11) 11
cholesterol (11) 11
clopidogrel (11) 11
electrocardiography (11) 11
hypertension (11) 11
myocardial infarction - blood (11) 11
risk (11) 11
ticlopidine - analogs & derivatives (11) 11
biomarkers (10) 10
clinical trials (10) 10
myocardial infarction - mortality (10) 10
platelet aggregation inhibitors - therapeutic use (10) 10
statins (10) 10
biomarkers - blood (9) 9
cardiovascular agents (9) 9
coronary artery disease (9) 9
follow-up studies (9) 9
prognosis (9) 9
atherosclerosis (8) 8
clinical outcomes (8) 8
coronary vessels (8) 8
dose-response relationship, drug (8) 8
drug therapy, combination (8) 8
prevention (8) 8
ticlopidine - therapeutic use (8) 8
transluminal angioplasty (8) 8
acute coronary syndrome - blood (7) 7
coronary artery bypass (7) 7
heart failure (7) 7
myocardial infarction - therapy (7) 7
patient outcomes (7) 7
percutaneous coronary intervention (7) 7
adult (6) 6
association (6) 6
enzymes (6) 6
heart-disease (6) 6
heart-failure (6) 6
low density lipoproteins (6) 6
myocardial infarction (6) 6
myocardial infarction - epidemiology (6) 6
myocardial infarction - physiopathology (6) 6
retrospective studies (6) 6
therapy (6) 6
thrombolytic therapy (6) 6
thrombolytic therapy - methods (6) 6
time factors (6) 6
unstable angina (6) 6
variables (6) 6
acute coronary syndrome - drug therapy (5) 5
aggregation (5) 5
artery-disease (5) 5
body mass index (5) 5
c-reactive protein (5) 5
events (5) 5
health aspects (5) 5
hospitalization (5) 5
hospitals (5) 5
lipids (5) 5
low density lipoprotein (5) 5
monoclonal antibodies (5) 5
multivariate analysis (5) 5
outcomes (5) 5
patients (5) 5
platelet aggregation inhibitors - administration & dosage (5) 5
randomized controlled trials as topic (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 10, pp. 1082 - 1115
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 24, pp. 2638 - 2651
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 61, Issue 12, pp. 1240 - 1249
Objectives The aims of this study were to assess the prognostic value of cardiac troponin I levels, measured with a new high-sensitivity assay, in low-risk... 
Cardiovascular | Internal Medicine | coronary artery disease | natriuretic peptides | cardiovascular death | troponin | Cardiovascular death | Natriuretic Peptides | Troponin | Coronary artery disease | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-FAILURE | MYOCARDIAL-ISCHEMIA | RISK | SERUM | RELEASE | T ASSAY | ASSOCIATION | Myocardial Infarction - blood | Myocardial Infarction - mortality | Prognosis | Age Factors | Follow-Up Studies | United States | Humans | Statistics as Topic | Heart Failure - blood | Coronary Artery Disease - blood | Glomerular Filtration Rate - physiology | Cause of Death | Troponin I - blood | Glomerular Filtration Rate - drug effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Peptide Fragments - blood | Heart Failure - diagnosis | Natriuretic Peptide, Brain - blood | Heart Failure - mortality | Risk Factors | Survival Rate | Coronary Artery Disease - drug therapy | Coronary Artery Disease - mortality | Heart Failure - drug therapy | Myocardial Infarction - drug therapy | Coronary Artery Disease - diagnosis | Indoles - therapeutic use | Heart failure | Medical colleges | C-reactive protein | Cardiac patients | Angiotensin | Coronary heart disease | Natriuretic peptides | Cardiology | Hypertension | Enzymes | Heart attacks | Laboratories | Mortality | Medical records | Cardiovascular disease | Confidence intervals | Variables | Diabetes | Drug therapy | Acute coronary syndromes | Shipments
Journal Article
Journal of Thoracic and Cardiovascular Surgery, The, ISSN 0022-5223, 2016, Volume 152, Issue 5, pp. 1243 - 1275
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 67, Issue 10, pp. 1145 - 1154
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 173, pp. 94 - 101
Background Despite current therapies, patients with vascular disease remain at high risk for major adverse cardiovascular events. Low-density lipoprotein... 
Cardiovascular | FAMILIAL HYPERCHOLESTEROLEMIA | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | EVOLOCUMAB AMG 145 | STATIN THERAPY | LDL-C | LOW-DENSITY-LIPOPROTEIN | PRIMARY-PREVENTION TRIAL | MONOCLONAL-ANTIBODY | PLACEBO-CONTROLLED TRIAL | CORONARY-HEART-DISEASE | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Proprotein Convertases - antagonists & inhibitors | United States - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Male | Incidence | Dose-Response Relationship, Drug | Cholesterol, VLDL - drug effects | Injections, Subcutaneous | Lipoproteins, LDL - drug effects | Cardiovascular Diseases - blood | Cardiovascular Diseases - epidemiology | Female | Serine Endopeptidases | Drug Therapy, Combination | Survival Rate - trends | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Risk Factors | Treatment Outcome | Cholesterol, VLDL - blood | Australia - epidemiology | Antibodies, Monoclonal - administration & dosage | Norway - epidemiology | United Kingdom - epidemiology | Lipoproteins, LDL - blood | Proprotein Convertase 9 | Monoclonal antibodies | Blood circulation disorders | Low density lipoproteins | Risk factors | Vascular diseases | Clinical trials | Cardiovascular disease | Lipids | Cardiovascular diseases | Low density lipoprotein | Statins | Morbidity
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 64, Issue 24, pp. 2645 - 2687
Journal Article